Antony Letai

1.8k total citations
11 papers, 840 citations indexed

About

Antony Letai is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Antony Letai has authored 11 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Antony Letai's work include Cell death mechanisms and regulation (7 papers), RNA Interference and Gene Delivery (3 papers) and Cancer Mechanisms and Therapy (2 papers). Antony Letai is often cited by papers focused on Cell death mechanisms and regulation (7 papers), RNA Interference and Gene Delivery (3 papers) and Cancer Mechanisms and Therapy (2 papers). Antony Letai collaborates with scholars based in United States, United Kingdom and Switzerland. Antony Letai's co-authors include Joan Montero, Özgür Kütük, Adrienne M. Flanagan, Andreas Weihofen, Anne Berger, Giuseppe P. Cortese, Matthew J. LaVoie, Selçuk Çolak, Cheryl Zimberlin and Evelyn Fessler and has published in prestigious journals such as Cancer Research, Human Molecular Genetics and Cell Death and Differentiation.

In The Last Decade

Antony Letai

11 papers receiving 836 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Antony Letai United States	11	545	303	163	104	94	11	840
Sandeep Nambiar Germany	14	674 1.2×	344 1.1×	218 1.3×	121 1.2×	92 1.0×	26	948
Alper Yetil United States	5	951 1.7×	322 1.1×	208 1.3×	141 1.4×	43 0.5×	5	1.2k
Ricardo E. Perez United States	16	602 1.1×	375 1.2×	168 1.0×	137 1.3×	107 1.1×	42	960
Ho-Chou Tu United States	8	861 1.6×	167 0.6×	273 1.7×	120 1.2×	128 1.4×	9	1.1k
Trine Bøttzauw Denmark	6	683 1.3×	281 0.9×	140 0.9×	75 0.7×	138 1.5×	6	978
Megan J. Bywater Australia	12	1.1k 2.0×	278 0.9×	149 0.9×	115 1.1×	59 0.6×	24	1.3k
Richard Lilischkis Germany	12	679 1.2×	252 0.8×	82 0.5×	82 0.8×	138 1.5×	16	974
Apoorva Baluapuri Germany	18	886 1.6×	250 0.8×	145 0.9×	109 1.0×	40 0.4×	25	1.1k
Raouf Fetni Canada	15	481 0.9×	220 0.7×	97 0.6×	67 0.6×	47 0.5×	34	857
Marco Cirò Italy	10	859 1.6×	320 1.1×	225 1.4×	83 0.8×	98 1.0×	11	1.1k

Countries citing papers authored by Antony Letai

Since Specialization

Citations

This map shows the geographic impact of Antony Letai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antony Letai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antony Letai more than expected).

Fields of papers citing papers by Antony Letai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antony Letai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antony Letai. The network helps show where Antony Letai may publish in the future.

Co-authorship network of co-authors of Antony Letai

This figure shows the co-authorship network connecting the top 25 collaborators of Antony Letai. A scholar is included among the top collaborators of Antony Letai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antony Letai. Antony Letai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Montero, Joan & Antony Letai. (2017). Why do BCL-2 inhibitors work and where should we use them in the clinic?. Cell Death and Differentiation. 25(1). 56–64. 243 indexed citations

Gunda, Viswanath, Kristopher A. Sarosiek, Eran Brauner, et al.. (2017). Inhibition of MAPKinase pathway sensitizes thyroid cancer cells to ABT-737 induced apoptosis. Cancer Letters. 395. 1–10. 16 indexed citations

Marusyk, Andriy, Doris P. Tabassum, Michalina Janiszewska, et al.. (2016). Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes. Cancer Research. 76(22). 6495–6506. 96 indexed citations

Zhao, Jianjun, Yiguo Hu, Jianhong Lin, et al.. (2015). Targeting the miR-221–222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma. Cancer Research. 75(20). 4384–4397. 72 indexed citations

Çolak, Selçuk, Cheryl Zimberlin, Evelyn Fessler, et al.. (2014). Decreased mitochondrial priming determines chemoresistance of colon cancer stem cells. Cell Death and Differentiation. 21(7). 1170–1177. 91 indexed citations

Bah, Nourdine, Laurent Maillet, Jeremy Ryan, et al.. (2014). Bcl-xL controls a switch between cell death modes during mitotic arrest. Cell Death and Disease. 5(6). e1291–e1291. 53 indexed citations

Murphy, Áine C., John J. Noonan, Seán M. Kilbride, et al.. (2013). Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis. APOPTOSIS. 19(4). 629–642. 41 indexed citations

Barbone, Dario, Jeremy Ryan, Nikita Kolhatkar, et al.. (2011). The Bcl-2 repertoire of mesothelioma spheroids underlies acquired apoptotic multicellular resistance. Cell Death and Disease. 2(6). e174–e174. 41 indexed citations

Kütük, Özgür & Antony Letai. (2010). Displacement of Bim by Bmf and Puma rather than increase in Bim level mediates paclitaxel-induced apoptosis in breast cancer cells. Cell Death and Differentiation. 17(10). 1624–1635. 72 indexed citations

10.

Berger, Anne, et al.. (2009). Parkin selectively alters the intrinsic threshold for mitochondrial cytochrome c release. Human Molecular Genetics. 18(22). 4317–4328. 69 indexed citations

11.

Flanagan, Adrienne M. & Antony Letai. (2007). BH3 domains define selective inhibitory interactions with BHRF-1 and KSHV BCL-2. Cell Death and Differentiation. 15(3). 580–588. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact